A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Issue 4 (19th August 2014)
- Record Type:
- Journal Article
- Title:
- A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Issue 4 (19th August 2014)
- Main Title:
- A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis
- Authors:
- Caga, Jashelle
Ramsey, Eleanor
Hogden, Anne
Mioshi, Eneida
Kiernan, Matthew C. - Abstract:
- <abstract abstract-type="normal"> <title>Abstract</title> <sec id="sec1"> <title>Objective:</title> <p>Recognizing depressive symptoms in patients with amyotrophic lateral sclerosis (ALS) remains problematic given the potential overlap with the normal psychological responses to a terminal illness. Understanding mental health and disease-related risk factors for depression is key to identifying psychological morbidity. The present study aimed to determine the prevalence of depressive symptoms in ALS and to explore mental health and disease-related risk factors for depression.</p> </sec> <sec id="sec2"> <title>Method:</title> <p>Structured medical and psychiatric history questionnaires and a validated depression scale (Depression, Anxiety, Stress Scale–21) were completed by 27 ALS patients (60% female; 59% limb onset; age 65.11 ± <italic>SE</italic> 2.21) prior to their initial review at a multidisciplinary clinic. Physical function was assessed with the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS–R).</p> </sec> <sec id="sec3"> <title>Results:</title> <p>At the time of initial assessment, 44% of patients had a previous psychiatric history, although the majority (62%) reported no symptoms of depression. The mean ALSFRS–R score was 37.78 ± <italic>SE</italic> 1.22, with an average diagnostic interval of 16.04 ± <italic>SE</italic> 2.39 months. Logistic regression analysis revealed that the length of the diagnostic interval alone predicted depressive symptoms<abstract abstract-type="normal"> <title>Abstract</title> <sec id="sec1"> <title>Objective:</title> <p>Recognizing depressive symptoms in patients with amyotrophic lateral sclerosis (ALS) remains problematic given the potential overlap with the normal psychological responses to a terminal illness. Understanding mental health and disease-related risk factors for depression is key to identifying psychological morbidity. The present study aimed to determine the prevalence of depressive symptoms in ALS and to explore mental health and disease-related risk factors for depression.</p> </sec> <sec id="sec2"> <title>Method:</title> <p>Structured medical and psychiatric history questionnaires and a validated depression scale (Depression, Anxiety, Stress Scale–21) were completed by 27 ALS patients (60% female; 59% limb onset; age 65.11 ± <italic>SE</italic> 2.21) prior to their initial review at a multidisciplinary clinic. Physical function was assessed with the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS–R).</p> </sec> <sec id="sec3"> <title>Results:</title> <p>At the time of initial assessment, 44% of patients had a previous psychiatric history, although the majority (62%) reported no symptoms of depression. The mean ALSFRS–R score was 37.78 ± <italic>SE</italic> 1.22, with an average diagnostic interval of 16.04 ± <italic>SE</italic> 2.39 months. Logistic regression analysis revealed that the length of the diagnostic interval alone predicted depressive symptoms (χ<sup>2</sup>(3, <italic>n</italic> = 26) = 9.21, Odds Ratio (<italic>OR</italic>) = 1.12, <italic>p</italic> &lt; 0.05.</p> </sec> <sec id="sec4"> <title>Significance of Results:</title> <p>The illness experiences of ALS patients rather than established mental health risk factors influence the manifestation of depressive symptoms in the early stages of the disease, with clinical implications for the assessment and treatment of psychological morbidity. Patients with lengthy diagnostic intervals may be prime targets for psychological assessment and intervention, especially in the absence of ALS-specific tests and biomarkers.</p> </sec> </abstract> … (more)
- Is Part Of:
- Palliative & supportive care. Volume 13:Issue 4(2015)
- Journal:
- Palliative & supportive care
- Issue:
- Volume 13:Issue 4(2015)
- Issue Display:
- Volume 13, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 13
- Issue:
- 4
- Issue Sort Value:
- 2015-0013-0004-0000
- Page Start:
- 1019
- Page End:
- 1024
- Publication Date:
- 2014-08-19
- Subjects:
- Palliative treatment -- Great Britain -- Periodicals
616.029 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=PAX&bVolume=n&volumeId=1#loc1 ↗
- DOI:
- 10.1017/S1478951514000881 ↗
- Languages:
- English
- ISSNs:
- 1478-9515
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 3437.xml